Pierrepont Therapeutics

Pierrepont Therapeutics develops targeted therapeutic treatments for genetically defined Primary Mitochondrial Diseases. The company focuses on novel clinical stage treatments addressing specific patient populations with nuclear and mitochondrial DNA mutations. This focus addresses the unmet medical need in a complex disease category historically overlooked by the pharmaceutical industry.

Traction –/10

Pittsburgh, United States · HQ

250+ followers

Biotechnology

Updated 5 months ago

Funding

Funding rounds are not available yet.

Founders

1 founder

Dan DiPietro

Biotechnology

Product

Features

Pierrepont Therapeutics develops targeted therapeutic treatments for genetically defined Primary Mitochondrial Diseases. The company focuses on novel clinical stage treatments addressing specific patient populations with nuclear and mitochondrial DNA mutations. This focus addresses the unmet medical need in a complex disease category historically overlooked by the pharmaceutical industry.